Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
60 participants
INTERVENTIONAL
2022-07-25
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Safety and Performance Outcomes of Eyedeal IOL Implantation After Cataract Removal
NCT05776095
Study on Visual Performance of a Monofocal Intraocular Lens
NCT04740788
Clinical Investigation of the Multifocal IOL POD F GF in Cataracteous Eyes
NCT04699266
Impact of a Novel Extended Depth of Focus Intraocular Lens on Visual and Lifestyle Enhancement
NCT04570579
Assessment of Visual Function and Optics in Intraocular Lenses
NCT01654159
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AVL200 IOL
The AVL200 is a modular fluid-filled, shape-changing intraocular lens (IOL) designed to restore visual function across a range of focal points
AVL200 IOL
The AVL200 is an intraocular lens surgically implanted in the eye after cataract surgery.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AVL200 IOL
The AVL200 is an intraocular lens surgically implanted in the eye after cataract surgery.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Best corrected distance visual acuity between 20/40 and 20/200
* Potential distance visual acuity of 20/32 or better
* Corneal astigmatism ≤ 1.5 diopters
Exclusion Criteria
* Previous corneal surgery or significant corneal abnormalities
* Ocular pathology or degenerative disorder having potential to impair visual acuity
* Pupil abnormality
* Intraoperative cataract surgery complications that could affect IOL implantation or positioning
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Atia Vision
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ashvin Agarwal, MD
Role: PRINCIPAL_INVESTIGATOR
Dr. Agarwals Eye Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dr Agarwal's Eye Hospital
Chennai, Tamal Nadu, India
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CP100962
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.